Evidence map›Paper›PMID 20435097›Full record

ReviewBiochimica et biophysica acta2011

Nanoscale engineering of extracellular matrix-mimetic bioadhesive surfaces and implants for tissue engineering.

Asha Shekaran, Andres J Garcia

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Lateral Spacing of TiOBiomimetics (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Graphene-Based Scaffolds for Regenerative Medicine.Nanomaterials (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Article
  9. Enhanced Biocompatibility in Anodic TaONanoscale research letters · 2017
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Asha ShekaranPetit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA.
Andres J Garcia

Funding

Integrin-specific implant surfaces for bone repairR01EB004496 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI GARCIA, ANDRES J · 2005 to 2008
$1.4M
NIBIB NIH HHS R01 EB004496
6 · The paper itself

Abstract

backgroundThe goal of tissue engineering is to restore tissue function using biomimetic scaffolds which direct desired cell fates such as attachment, proliferation and differentiation. Cell behavior in vivo is determined by a complex interaction of cells with extracellular biosignals, many of which exist on a nanoscale. Therefore, recent efforts in tissue engineering biomaterial development have focused on incorporating extracellular matrix- (ECM) derived peptides or proteins into biomaterials in order to mimic natural ECM. Concurrent advances in nanotechnology have also made it possible to manipulate protein and peptide presentation on surfaces on a nanoscale level. SCOPE OF REVIEW: This review discusses protein and peptide nanopatterning techniques and examples of how nanoscale engineering of bioadhesive materials may enhance outcomes for regenerative medicine. MAJOR

conclusionsSynergy between ECM-mimetic tissue engineering and nanotechnology fields can be found in three major strategies: (1) Mimicking nanoscale orientation of ECM peptide domains to maintain native bioactivity, (2) Presenting adhesive peptides at unnaturally high densities, and (3) Engineering multivalent ECM-derived peptide constructs. GENERAL SIGNIFICANCE: Combining bioadhesion and nanopatterning technologies to allow nanoscale control of adhesive motifs on the cell-material interface may result in exciting advances in tissue engineering. This article is part of a Special Issue entitled Nanotechnologies - Emerging Applications in Biomedicine.

Indexed as

BiomimeticsNanotechnologyProstheses and ImplantsTissue EngineeringAnimalsBiocompatible MaterialsCell AdhesionExtracellular MatrixHumansBiocompatible Materials

Identifiers

PMID20435097
PMCPMC2924948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.